Government Initiatives and Major Projects
100,000 Genomes Project
The Project was established by Genomics England to sequence 100,000 genomes from around 85,000 NHS patients affected by a rare disease, or cancer. The aim of the project was to create a new genomic medicine service for the NHS, ensuring that patients see the benefits from diagnostic technologies and personalised medicine.
The Electronic Medical Records and Genomics (eMERGE) Network is a National Institutes of Health (NIH)-organized and funded consortium of U.S. medical research institutions. The primary goal of the eMERGE Network is to develop, disseminate, and apply approaches to research that combine biorepositories with electronic medical record (EMR) systems for genomic discovery and genomic medicine implementation research.
Initially set up to support the delivery of the 100,000 Genomes Project, the GEP are now educating the NHS work force about the benefits and impact of genomics on patient treatment and care. The training and resources they provide to healthcare professionals are enabling advances in genomics to be integrated effectively into clinical care.
The NHRI advances genomics research at the National Institute of Health.
The Precision Medicine Imitative is a long-term research endeavor, involving the National Institutes of Health (NIH) and multiple other research centers, which aims to understand how a person’s genetics, environment, and lifestyle can help determine the best approach to prevent or treat disease.
The Qatar Genome Programme (QGP) is a population-based project, generating large databases that combine whole genome sequencing and other omics data with the comprehensive phenotypic data collected at Qatar Biobank.
UK Biobank is a national and international health resource with unparalleled research opportunities, open to all bona fide health researchers. The UK Biobank is following the health and well-being of 500,000 volunteer participants and provides health information, which does not identify them, to approved researchers in the UK and overseas, from academia and industry.